Commonwealth Equity Services’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $459K | Buy |
4,201
+27
| +0.6% | +$2.57K | ﹤0.01% | 3281 |
|
|
2025
Q4 | $338K | Sell |
4,174
-124
| -3% | -$10.7K | ﹤0.01% | 3548 |
|
|
2025
Q3 | $376K | Sell |
4,298
-3,486
| -45% | -$311K | ﹤0.01% | 3428 |
|
|
2025
Q2 | $647K | Buy |
7,784
+3
| +0% | +$251 | ﹤0.01% | 2948 |
|
|
2025
Q1 | $653K | Sell |
7,781
-13
| -0.2% | -$1.21K | ﹤0.01% | 2822 |
|
|
2024
Q4 | $718K | Sell |
7,794
-2,171
| -22% | -$209K | ﹤0.01% | 2674 |
|
|
2024
Q3 | $926K | Sell |
9,965
-490
| -5% | -$42.5K | ﹤0.01% | 2413 |
|
|
2024
Q2 | $860K | Sell |
10,455
-557
| -5% | -$40.9K | ﹤0.01% | 2395 |
|
|
2024
Q1 | $731K | Sell |
11,012
-17
| -0.2% | -$1.05K | ﹤0.01% | 2485 |
|
|
2023
Q4 | $626K | Buy |
11,029
+7
| +0.1% | +$367 | ﹤0.01% | 2527 |
|
|
2023
Q3 | $600K | Buy |
11,022
+64
| +0.6% | +$3.79K | ﹤0.01% | 2439 |
|
|
2023
Q2 | $737K | Buy |
10,958
+66
| +0.6% | +$4.03K | ﹤0.01% | 2327 |
|
|
2023
Q1 | $560 | Buy |
10,892
+25
| +0.2% | +$1.21K | ﹤0.01% | 2457 |
|
|
2022
Q4 | $500K | Buy |
10,867
+84
| +0.8% | +$3.93K | ﹤0.01% | 2471 |
|
|
2022
Q3 | $546K | Buy |
10,783
+19
| +0.2% | +$949 | ﹤0.01% | 2334 |
|
|
2022
Q2 | $490K | Sell |
10,764
-189
| -2% | -$8.45K | ﹤0.01% | 2415 |
|
|
2022
Q1 | $509K | Sell |
10,953
-505
| -4% | -$22.6K | ﹤0.01% | 2506 |
|
|
2021
Q4 | $575K | Sell |
11,458
-136
| -1% | -$7.03K | ﹤0.01% | 2410 |
|
|
2021
Q3 | $615K | Buy |
11,594
+1,603
| +16% | +$90.3K | ﹤0.01% | 2314 |
|
|
2021
Q2 | $609K | Buy |
9,991
+604
| +6% | +$32.1K | ﹤0.01% | 2315 |
|
|
2021
Q1 | $457K | Sell |
9,387
-345
| -4% | -$16.2K | ﹤0.01% | 2402 |
|
|
2020
Q4 | $394K | Buy |
9,732
+836
| +9% | +$29.9K | ﹤0.01% | 2325 |
|
|
2020
Q3 | $289K | Sell |
8,896
-2,395
| -21% | -$71.9K | ﹤0.01% | 2387 |
|
|
2020
Q2 | $298K | Sell |
11,291
-383
| -3% | -$10K | ﹤0.01% | 2283 |
|
|
2020
Q1 | $290K | Sell |
11,674
-85
| -0.7% | -$2.63K | ﹤0.01% | 2096 |
|
|
2019
Q4 | $422K | Buy |
11,759
+11
| +0.1% | +$380 | ﹤0.01% | 2043 |
|
|
2019
Q3 | $401K | Sell |
11,748
-397
| -3% | -$12.7K | ﹤0.01% | 1991 |
|
|
2019
Q2 | $339K | Buy |
12,145
+31
| +0.3% | +$861 | ﹤0.01% | 2104 |
|
|
2019
Q1 | $375K | Buy |
12,114
+1,141
| +10% | +$30.4K | ﹤0.01% | 1979 |
|
|
2018
Q4 | $259K | Buy |
10,973
+2,092
| +24% | +$57.1K | ﹤0.01% | 2133 |
|
|
2018
Q3 | $344K | Buy |
8,881
+9
| +0.1% | +$324 | ﹤0.01% | 2057 |
|
|
2018
Q2 | $297K | Buy |
8,872
+18
| +0.2% | +$640 | ﹤0.01% | 2132 |
|
|
2018
Q1 | $320K | Buy |
8,854
+425
| +5% | +$14.7K | ﹤0.01% | 2019 |
|
|
2017
Q4 | $268K | Buy |
8,429
+7
| +0.1% | +$240 | ﹤0.01% | 2127 |
|
|
2017
Q3 | $315K | Sell |
8,422
-195
| -2% | -$6.64K | ﹤0.01% | 1946 |
|
|
2017
Q2 | $269K | Buy |
8,617
+18
| +0.2% | +$520 | ﹤0.01% | 1995 |
|
|
2017
Q1 | $212K | Buy |
+8,599
| New | +$202K | ﹤0.01% | 2103 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Commonwealth Equity Services's LMAT Position: Q1 2026 in Review
Commonwealth Equity Services increased its LeMaitre Vascular (LMAT) stake by 0.65% in Q1 2026, buying an estimated $2.57K and bringing the position to 4,201 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #3281.
Commonwealth Equity Services first reported a position in LMAT in Q1 2017 and has held it in 37 quarters since. The position peaked at $926K in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Commonwealth Equity Services held 4,201 shares of LeMaitre Vascular worth $459K as of Q1 2026.
- Commonwealth Equity Services bought 27 LeMaitre Vascular shares in Q1 2026, an estimated $2.57K.
- LeMaitre Vascular made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #3281 holding.
- Commonwealth Equity Services first reported a position in LeMaitre Vascular in Q1 2017 and has held it in 37 quarters since.
- Commonwealth Equity Services's LeMaitre Vascular position peaked at $926K in Q3 2024.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.